Mammalian and bacterial nitric oxide synthase inhibitors
Compounds and related methods for inhibition of mammalian and bacterial nitric oxide synthase.
1. A compound of a formula
wherein R 1 is selected from H, alkyl and amino moieties; L 1 is a divalent linker moiety selected from a covalent bond, alkylene and substituted alkylene moieties, said alkylene substituents selected from hydroxy, amino, aminoalkyl, aza (—NH—), alkyl (R) substituted aza (—NR—) and amino substituents and combinations thereof; R 3 is selected from H, alkyl, halo, haloalkyl, cyano and amino moieties and combinations thereof; X is selected from CH, CR 3 and N; L 2 is an alkylamino moiety or a cycloalkylamino moiety; and R 2 is selected from amino, substituted amino and optionally-substituted cycloalkyl, heterocycloalkyl, aryl and heteroaryl moieties, said substituents selected from amino, halo, alkyl, cycloalkyl and heterocycloalkyl substituents and divalent alkylene and heteroatom-substituted alkylene substituents, or a salt thereof.
2. The compound of claim 1 of a formula
wherein n is 1-3.
3. The compound of claim 2 wherein n is 2, L 2 is selected from —NH(CH 2 ) m — and —N(R)(CH 2 ) m — moieties, where m is 0-4; R is selected from alkyl and cycloalkyl moieties; and R 2 is selected from amine, alkyl- and cycloalkyl-substituted amine moieties and optionally-substituted aryl and heteroaryl moieties.
4. The compound of claim 1 of a formula
wherein R 1 is selected from H and methyl moieties; X and Y are independently selected from CH, CR 3 and N, providing both X and Y are not N; Z is selected from N and NH; m is an integer selected from 0-3; and R 4 is selected from H, alkyl, cycloalkyl and divalent alkylene moieties; and R 5 and R 6 are independently selected from H, alkyl, cycloalkyl, optionally substituted aryl and heteroaryl moieties and divalent alkylene moieties, providing where m is 0, R 6 is selected from H and alkyl and R 4 and R 5 are independently selected from divalent alkylene moieties to provide together with NR 6 and Z, respectively, a heterocycloalkyl moiety.
5. The compound of claim 4 wherein Z is selected from N and NH; m is 0; and R 4 and R 5 are independently divalent alkylene moieties to provide a said heterocycloalkyl moiety.
6. The compound of claim 5 wherein Z is N and said heterocycloalkyl moiety is a piperazinyl moiety.
7. The compound of claim 5 wherein Z is NH and said heterocycloalkyl moiety is a piperidinyl moiety.
8. The compound of claim 4 wherein one of X and Y is N; R 3 is H; Z is N; R 4 is selected from H, alkyl and cycloalkyl; m is 2-3; R 5 and R 6 are independently selected from H, alkyl and cycloalkyl moieties.
9. The compound of claim 4 wherein X is CH and Y is CR 3 , where R 3 is selected from fluoro, trifluoromethyl and cyano substituents; R 4 is selected from H and alkyl; m is 2-3; R 5 and R 6 are independently selected from H, alkyl and cycloalkyl moieties.
10. The compound of claim 3 wherein n is 2; L 2 is —NH(CH 2 ) m —, where m is selected from 1 and 2; and R 2 is selected from pyridinyl and substituted phenyl moieties.
11. A compound of a formula
wherein R 1 is selected from H, alkyl and amino moieties; R 3 is H; L 2 is an alkylamino moiety or a cycloalkylamino moiety; and R 2 is selected from amino, substituted amino and optionally-substituted cycloalkyl, heterocycloalkyl, aryl and heteroaryl moieties, said substituents selected from amino, halo, alkyl, cycloalkyl and heterocycloalkyl substituents and divalent alkylene and heteroatom-substituted alkylene substituents, or a salt thereof.
12. The compound of claim 11 of a formula
wherein L 2 is an aza-substituted alkylene moiety, said substituent selected from —NH— and —NR— where R is alkyl; and R 2 is selected from halo-substituted phenyl and alkyl-substituted amino moieties.
13. The compound of claim 12 wherein said aza-substituted alkylene moiety is selected from CH 2 NH(CH 2 ) 2 —, CH 2 N(CH 3 )(CH 2 ) 2 —, —CH 2 NH(CH 2 ) 3 —, —CH 2 NHCH 2 — and N(CH 3 )(CH 2 ) 2 — moieties.
14. The compound of claim 1 wherein L 1 is selected from alkylene moieties; X is N; L 2 is an aza-substituted alkylene moiety; and R 2 is selected from alkyl-substituted amino moieties.
15. The compound of claim 14 wherein said aza-substituted alkylene moiety is selected from —CH 2 NH(CH 2 ) 2 —, CH 2 N(CH 3 )(CH 2 ) 2 —, —CH 2 NH(CH 2 ) 3 —, CH 2 N(CH 3 )(CH 2 ) 3 —, —CH 2 NHCH 2 — and N(CH 3 )(CH 2 ) 2 — moieties.
16. A compound of a formula
wherein R 1 is selected from H, alkyl and amino moieties; L 1 is a divalent linker moiety selected from substituted alkylene moieties, said alkylene substituents selected from amino and aminoalkyl substituents; R 3 is selected from H, alkyl, halo, haloalkyl, cyano and amino moieties and combinations thereof; X is selected from CH, CR 3 and N; L 2 is an alkylamino moiety or a cycloalkylamino moiety; and R 2 is selected from amino, substituted amino and optionally-substituted cycloalkyl, heterocycloalkyl, aryl and heteroaryl moieties, said substituents selected from amino, halo, alkyl, cycloalkyl and heterocycloalkyl substituents and divalent alkylene and heteroatom-substituted alkylene substituents, or a salt thereof.